NachrichtenKI-unterstützt

Carisma Therapeutics Joins 7th Annual Evercore ISI HealthCONx Conference To Share Industry Insights

Carisma CEO Steven Kelly to join a fireside chat at the Evercore ISI HealthCONx Conference on Dec 5. Webcast available on company site.

Von Simantini Singh Deo

Senior Content Writer

28. Nov. 2024Updated Jun 26, 2025 · 2 Min. Lesezeit

Teilen Als bevorzugte Quelle hinzufügen

Carisma Therapeutics Joins 7th Annual Evercore ISI HealthCONx Conference To Share Industry Insights — https://www.google.com/url?sa=i&url=https%3A%2F%2Fcarismatx.com%2F&psig=AOvVaw2sU09coVR9on080U0gGHaR&ust=1732875178316000&source=images&cd=vfe&opi=89978449&ved=0CAMQjB1qFwoTCMC4lZ3l_okDFQAAAAAdAAAAABAw

KI-unterstützte Berichterstattung

Reviewed by Simantini Singh Deo, Senior Content Writer

Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company dedicated to pioneering innovative immunotherapies, has announced that Steven Kelly, President and CEO, will take part in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. The session is scheduled for Thursday, December 5th at 9:35 am ET. An audio webcast of the discussion will be accessible on the Company's Investor Events page within the Investor Relations section of its website and will be available for a limited period after the event.

ThemenNachrichten

Written by

Simantini Singh Deo

Senior Content Writer

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.